The International Consortium for Personalised Medicine

Slides:



Advertisements
Similar presentations
Strengthening the Strategic Cooperation between the EU and Western Balkan Region in the field of ICT Research Input to panel discussion: Concrete actions.
Advertisements

eHealth Actions at European level
Research & Innovation Evolution from IMI1 to IMI2: challenges ahead Elmar Nimmesgern, PhD DG Research & Innovation 1.
Workshop on development of Agent- based models for the global economy and its markets 1 October 2010 Maria Geronymaki DG INFSO.H.2 ICT for Government &
Dorota Kilańska RN, PhD European Nursing Research Foundation (ENRF)
Science, research and developmentEuropean Commission Chile-EC S&T Agreement Brussels, 24 September 2002 Life Sciences, Genomics and Biotechnology for Health.
1 Progress report: DISCONTOOLS Project Morgane Delavergne DISCONTOOLS Project Manager, September 22nd, 2009 Mirror Group Meeting Châtelain Hotel, Brussels.
Director, DG RTD, Directorate International Cooperation
What do we mean when we talk about IMPACT? IAS Public Engagement and Impact 6 th November 2014.
1 Survey of Health, Ageing and Retirement in Europe Andrzej Ryś - Director Public Health European Commission DG SANCO 28 November 2008.
1 NEST New and emerging science and technology EUROPEAN COMMISSION - 6th Framework programme : Anticipating Scientific and Technological Needs.
Europe for eHealth: the way ahead eHealth 2006 conference, Tromso, Norway, May Peter Zangl, Deputy Director-General DG Information Society and.
Clinical trials in Framework programme 7 (FP7) EU Judita Kinkorová 2. Národní konference o doporučených postupech, Olomouc 13. listopadu 2010.
“ BIRD Project“ 1 Broadband Access, Innovation & Regional Development” Broadband Access, Innovation & Regional Development” Project Description Ulrich.
1 SMEs – a priority for FP6 Barend Verachtert DG Research Unit B3 - Research and SMEs.
United Nations Economic Commission for Europe Statistical Division Data Initiatives: The UNECE Gender Database and Website Victoria Velkoff On behalf of.
China July 2004 The European Union Programmes for EU-China Cooperation in ICT.
© Services GmbH Proposal writing: Part B 2/1/ St. Petersburg, May 18, 2011 Dr. Andrey Girenko
GENOMICS TO COMBAT RESISTANCE AGAINST ANTIBIOTICS IN COMMUNITY-ACQUIRED LRTI IN EUROPE (GRACE) H. Goossens (Coordinator), K. Loens (Manager), M. Ieven.
9th Meeting of the Steering Committee 1 / 26 Lisbon, 10 November 2009 Climate Impact Research (and Response) Coordination for a Larger Europe CIRCLE (2)
The 7th Framework Programme for Research: Strategy of international cooperation activities Robert Burmanjer Head of Unit, “International Scientific Cooperation.
IncoNet EaP is a project funded under the 7th European Framework Programme for research - Project number EU-Eastern Partnership STI Cooperation.
The European Transport Research Alliance - ETRA Prof. G. A. Giannopoulos Chairman, ETRA.
Partnerships Horizon 2020 / Eurostars expert: Dr. Radosław Piesiewicz.
“Preparing competitive grant proposals that match policy objectives - project proposal evaluators' viewpoint ” Despina Sanoudou, PhD FACMG Assistant Professor.
Introduction to The BECOTEPS project Workshop on the opportunities for new business concepts with the combined non-food biomass chains 7 th October 2009.
Dr Charmaine Gauci Superintendent of Public Health/Director General PH
Anne-Marie Yazbeck, PhD National Infoday, Sweden 2017
Richard Murrugarra – Centurion
Progress of 2016 Work Plan implementation by HIV, TB&AI EG
Open to the World Philippe Cupers European Commission
ITC - ETUC European Sectoral Social Dialogue in the construction industry Werner Buelen Tel : 02/ (ext.45)
Horizon 2020 – R&D Opportunities
2017 ComTech Innovation Summit in Healthcare, Austin
Dorota Kilańska RN, PhD European Nursing Research Foundation (ENRF)
FP6 Priority 1, Life Sciences Genomics and Biotechnology for Health
PLANNED ACTIONS – UPCOMING DUTIES
Strengthening the foundations of ERA
International Relations Sector and IR-ECO Group
The importance of SMEs for ITU
UNECE Work Session on Gender Statistics, Belgrade,
ICPerMed – an International Consortium
KOINNO -- German Competence Centre for Innovation Procurement
International cooperation in Health
EC initiative on Next Generation sequencing
MAES Working Group Meeting Brussels
Supporting CRVS Decade
Marine Strategy Framework Directive (MSFD)
EOSC Governance Development Forum
International Cooperation
Maximizing the value and the impact of health research in Europe
The new European Consensus on Development
EU health institutional and policy developments
The ERA.Net instrument Aims and benefits
Funding opportunities in illicit drugs research in H2020
DG AGRI, Unit F6 Bioenergy, biomass, forestry and climatic changes
National Cluster Platform Austria Dr
Statistics beyond the National Level –Regional Experiences
Need for a strong Commission for healthcare
JPIAMR Joint Research Calls – Update and Future Calls
Marine Strategy Framework Directive (MSFD)
FP6 Priority 1, Life Sciences Genomics and Biotechnology for Health
A joint initiative of African partners for the advancement of recognition and treatment of Rare Diseases in Africa.
Ðì SA Effective Monitoring and Evaluation of Progress on the SDGs Monitoring SDGs : the perspective of Armstat Learning Conference: Implementing.
Welcome Mid-Term ERA-NET SusAn Projects Seminar
Communication & Technology Research
League of Advanced European Neutron Sources
Our vision Knowledge creates a sustainable world
eContentplus 2007 Work Programme
Presentation transcript:

The International Consortium for Personalised Medicine Speaker Venue, Date

ICPerMed – An International Consortium More than 35 European and international partners Representing ministries, funding agencies and the European Commission (EC) International consortium model Aim: To coordinate and foster research to develop and evaluate personalised medicine approaches Venue

ICPerMed Vision Statement: Establish Europe as a global leader in personalised medicine research. Support the personalised medicine science base through a coordinated approach to research. Support research to investigate the benefits of personalised medicine to citizens and healthcare systems. Pave the way for personalised medicine approaches for citizens Research as driver of personalised medicine Venue

Personalised Medicine – A definition PM [ ] “refers to a medical model using Characterisation of individuals’ phenotypes and genotypes (e.g. molecular profiling, medical imaging, lifestyle data) for tailoring the right therapeutic strategy for the right person at the right time, and/or to determine the predisposition to disease and/or to deliver timely and targeted prevention". According to: Horizon 2020 and European Council Conclusions on personalised medicine for patients (2015/C 421/03) Venue

ICPerMed Governance Venue

ICPerMed Challenge Groups: The whole healthcare chain and beyond Venue

Development of the ICPerMed Action Plan Actionable research and support activities Input to national and European strategic discussion of research funders Released in March 2017 Venue

ICPerMed Action Plan - Structure A) Research activities: Data Technologies, Methods and Processes People Cross-Cutting B) Support activities: Structures Methods and Processes This slide is optional, it is basically the table of contents of the action plan.

Action Item Groups Aim: Report on implementation of ICPerMed Action Plan Report on ongoing activities (state-of-the-art report) Collect and present best-practice examples 5 groups with similar number of action items per group: Data and ICT – Enabling Technology Data and ICT – Improving Health Care Translational Research Health Economics, Regulation, Market Access People and Society

Partnering Tool Platform for research organisations to find potential cooperation partners Was used e.g. by ERA PerMed and Flagship Canada/EU call Ca. 250 entries so far Venue

Survey and Database Mapping Activity: Ongoing funding programmes in Personalised Medicine Survey sent to all ICPerMed members Results are available in the ICPerMed mapping database open to the public after simple registration Venue

ICPerMed Statements ICPerMed may issue joined statements on important issues in Personalised Medicine. First statement: May 2018 about the One Million Genomes Declaration https://www.icpermed.eu/en/statement-concerning-the-1-million-genomes-declaration.php Venue

ICPerMed State-of-the-Art Report Available on ICPerMed Website First year: Mainly report on ICPerMed Activities Future reports: More general overview over the field of Personalised Medicine Released June 2018 Venue

ICPerMed Workshop 2017 Innovative Concepts on Data Generation and use for Personalised Medicine Research Milan, June 26-27, 2017 Venue

ICPerMed Workshop 2017 „Data Generation and Use for Personalised Medicine Research“ Experts and funders Interdisciplinary working panels on: Primary Prevention Disease reclassification Impact of data in research Successful PM approaches New tools impact Workshop report available

Personalised Medicine in Action ICPerMed Events ICPerMed Conference 2018 Personalised Medicine in Action Berlin, November 20-21, 2018 Venue

ICPerMed Conference 2018 “Personalised Medicine in Action” - Focus on best practice examples in research & implementation and policy High-Level Keynote talks covering several aspects of PM Best practice sessions: Research & Implementation: Representatives of all relevant steps as speakers, e.g. researchers, clinicians, industry, payers, patients Policy: Examples on policy making and impact analyses from ICPerMed member countries ICPerMed Award

ICPerMed – Coordinating PM research Venue

More information about ICPerMed Mail: ICPerMed@dlr.de Internet: www.icpermed.eu